Neuberger Berman Group LLC Agios Pharmaceuticals, Inc. Transaction History

Neuberger Berman Group LLC

$121 Billion
Q4 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$26.68 - $34.81 $257,995 - $336,612	-9,670 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$29.58 - $49.78 $551,282 - $927,749	-18,637 Reduced 65.84%	9,670 $317,000
Q3 2021 Nov 12, 2021	SELL	$41.92 - $58.18 $195,556 - $271,409	-4,665 Reduced 14.15%	28,307 $1.3 Million
Q2 2021 Aug 13, 2021	SELL	$52.06 - $61.27 $279,041 - $328,407	-5,360 Reduced 13.98%	32,972 $1.81 Million
Q1 2021 May 13, 2021	SELL	$44.23 - $57.5 $53,120 - $69,057	-1,201 Reduced 3.04%	38,332 $1.98 Million
Q4 2020 Feb 10, 2021	SELL	$33.21 - $46.54 $34,804 - $48,773	-1,048 Reduced 2.58%	39,533 $1.71 Million
Q3 2020 Nov 12, 2020	SELL	$33.87 - $55.93 $298,394 - $492,743	-8,810 Reduced 17.84%	40,581 $1.42 Million
Q2 2020 Aug 13, 2020	SELL	$34.45 - $53.48 $48,264 - $74,925	-1,401 Reduced 2.76%	49,391 $2.64 Million
Q1 2020 May 14, 2020	SELL	$31.52 - $53.81 $844,925 - $1.44 Million	-26,806 Reduced 34.54%	50,792 $1.8 Million
Q4 2019 Feb 12, 2020	BUY	$30.08 - $50.59 $327,841 - $551,380	10,899 Added 16.34%	77,598 $3.71 Million
Q3 2019 Nov 13, 2019	SELL	$32.4 - $49.58 $791,856 - $1.21 Million	-24,440 Reduced 26.82%	66,699 $2.16 Million
Q2 2019 Aug 13, 2019	SELL	$46.17 - $68.1 $213,490 - $314,894	-4,624 Reduced 4.83%	91,139 $4.55 Million
Q1 2019 May 13, 2019	SELL	$45.92 - $67.67 $7.71 Million - $11.4 Million	-167,853 Reduced 63.67%	95,763 $6.46 Million
Q4 2018 Feb 12, 2019	SELL	$42.73 - $76.53 $3.41 Million - $6.11 Million	-79,775 Reduced 23.23%	263,616 $12.2 Million
Q3 2018 Nov 13, 2018	BUY	$71.67 - $91.95 $360,930 - $463,060	5,036 Added 1.49%	343,391 $26.5 Million
Q2 2018 Aug 13, 2018	BUY	$73.22 - $99.55 $7.57 Million - $10.3 Million	103,415 Added 44.02%	338,355 $28.5 Million
Q1 2018 May 08, 2018	BUY	$59.83 - $86.53 $13.1 Million - $18.9 Million	218,730 Added 1349.35%	234,940 $19.2 Million
Q4 2017 Feb 14, 2018	BUY	$52.12 - $72.33 $844,865 - $1.17 Million	16,210	16,210 $927,000

Others Institutions Holding AGIO

# of Institutions

244

Shares Held

59.9M

Call Options Held

270K

Put Options Held

332K

Farallon Capital Management LLC San Francisco, CA

5.67M
Shares

$191 Million
0.99% of portfolio
Vanguard Group Inc Valley Forge, PA

5.63M
Shares

$189 Million
0.0% of portfolio
Black Rock Inc. New York, NY

4.86M
Shares

$163 Million
0.0% of portfolio
Bellevue Group Ag Kuesnacht, V8

3.52M
Shares

$118 Million
2.3% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.42M
Shares

$81.5 Million
0.01% of portfolio

View Full List

About AGIOS PHARMACEUTICALS, INC.

Ticker AGIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,818,000
Market Cap $1.84B
Description
Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...

More about AGIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account